Nan Lv1, Christof Karmonik2, Shiyue Chen3, Xinrui Wang3, Yibin Fang1, Qinghai Huang1, Jianmin Liu1. 1. Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai, China. 2. MRI Core, Houston Methodist Research Institute, Houston, Texas. 3. Department of Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Abstract
BACKGROUND: The rupture risk assessment of unruptured intracranial aneurysms (IAs) is still challenging. Aneurysm wall enhancement (AWE) on vessel wall magnetic resonance imaging (VW-MRI) is suggested as a potential marker for wall inflammation, but its relationship with rupture risk of unruptured IAs has not been well described. OBJECTIVE: To investigate the correlation between AWE and conventional rupture risk factor of unruptured IAs. METHODS: Clinical data and VW-MRI images were retrospectively reviewed in patients with unruptured IAs from January 2015 to December 2016 in our center. One hundred ten patients harboring 140 unruptured IAs were included. The presence of AWE was determined by comparing the postcontrast VW-MRI images with the precontrast ones. The rupture risk based on the PHASES score was calculated for each case. Univariate and multivariate analysis were performed to investigate the association of AWE with rupture risk and other conventional risk factors. RESULTS: AWE was present in 82 (58.6%) lesions. Unruptured IAs with AWE had significantly larger size (P < .001), more irregular shape (P = .003), and different distribution of locations (P = .023) comparing with aneurysms without AWE. The rupture risk score of AWE group was significantly higher than non-AWE group (P < .001). Aneurysm size (odds ratio = 1.536; 95% confidential interval 1.312-1.798; P < .001) and location (odds ratio = 1.592; 95% confidential interval 1.237-2.049; P < .001) were independently related with AWE in multivariate analysis. CONCLUSION: The presence of AWE on VW-MRI was highly associated with conventional rupture-related characteristics, including aneurysmal size and location, and was detected more frequently in unruptured IAs with high rupture risk based on the PHASES score.
BACKGROUND: The rupture risk assessment of unruptured intracranial aneurysms (IAs) is still challenging. Aneurysm wall enhancement (AWE) on vessel wall magnetic resonance imaging (VW-MRI) is suggested as a potential marker for wall inflammation, but its relationship with rupture risk of unruptured IAs has not been well described. OBJECTIVE: To investigate the correlation between AWE and conventional rupture risk factor of unruptured IAs. METHODS: Clinical data and VW-MRI images were retrospectively reviewed in patients with unruptured IAs from January 2015 to December 2016 in our center. One hundred ten patients harboring 140 unruptured IAs were included. The presence of AWE was determined by comparing the postcontrast VW-MRI images with the precontrast ones. The rupture risk based on the PHASES score was calculated for each case. Univariate and multivariate analysis were performed to investigate the association of AWE with rupture risk and other conventional risk factors. RESULTS: AWE was present in 82 (58.6%) lesions. Unruptured IAs with AWE had significantly larger size (P < .001), more irregular shape (P = .003), and different distribution of locations (P = .023) comparing with aneurysms without AWE. The rupture risk score of AWE group was significantly higher than non-AWE group (P < .001). Aneurysm size (odds ratio = 1.536; 95% confidential interval 1.312-1.798; P < .001) and location (odds ratio = 1.592; 95% confidential interval 1.237-2.049; P < .001) were independently related with AWE in multivariate analysis. CONCLUSION: The presence of AWE on VW-MRI was highly associated with conventional rupture-related characteristics, including aneurysmal size and location, and was detected more frequently in unruptured IAs with high rupture risk based on the PHASES score.
Authors: Jorge A Roa; Mario Zanaty; Carlos Osorno-Cruz; Daizo Ishii; Girish Bathla; Santiago Ortega-Gutierrez; David M Hasan; Edgar A Samaniego Journal: J Neurosurg Date: 2020-02-07 Impact factor: 5.115
Authors: James Feghali; Abhishek Gami; Risheng Xu; Christopher M Jackson; Rafael J Tamargo; Cameron G McDougall; Judy Huang; Justin M Caplan Journal: Neurosurg Rev Date: 2021-04-02 Impact factor: 3.042
Authors: Aisen Vivas; Julia Mikhal; Gabriela M Ong; Anna Eigenbrodt; Andries D van der Meer; Rene Aquarius; Bernard J Geurts; Hieronymus D Boogaarts Journal: Brain Sci Date: 2022-05-05
Authors: Jorge A Roa; Mario Zanaty; Daizo Ishii; Yongjun Lu; David K Kung; Robert M Starke; James C Torner; Pascal M Jabbour; Edgar A Samaniego; David M Hasan Journal: J Neurosurg Date: 2020-03-06 Impact factor: 5.115
Authors: Tuula Peñate Medina; Jan Philip Kolb; Gereon Hüttmann; Robert Huber; Oula Peñate Medina; Linh Ha; Patricia Ulloa; Naomi Larsen; Arianna Ferrari; Magdalena Rafecas; Mark Ellrichmann; Mariya S Pravdivtseva; Mariia Anikeeva; Jana Humbert; Marcus Both; Jennifer E Hundt; Jan-Bernd Hövener Journal: Front Immunol Date: 2021-06-24 Impact factor: 7.561
Authors: S Hadad; F Mut; B J Chung; J A Roa; A M Robertson; D M Hasan; E A Samaniego; J R Cebral Journal: AJNR Am J Neuroradiol Date: 2020-12-24 Impact factor: 3.825
Authors: Vanessa M Swiatek; Belal Neyazi; Jorge A Roa; Mario Zanaty; Edgar A Samaniego; Daizo Ishii; Yongjun Lu; I Erol Sandalcioglu; Sylvia Saalfeld; Philipp Berg; David M Hasan Journal: Neurosurgery Date: 2021-09-15 Impact factor: 5.315